Cigna Group (CI) stock

CINYSEHospital & Medical Service PlansFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026Score 8/30

$298.23−0.18 (-0.06%)

Close on Oct 30, 2026Market cap $78.80BP/E –Yield 2.03%

Earnings

Cigna's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report

Oct 29, 2026

Q3 FY2026 · estimated, before the open

Revenue, Q2 FY2026

$71.70B

+6.7% on a year earlier

Adjusted income from operations, per share, Q2 FY2026

$7.78

$7.20 a year earlier

Latest guidance

Raised

Jul 30, 2026 · 4 items

Quarterly results

Revenue and earnings per share from each of Cigna's earnings releases, newest first

Quarter	Reported	Revenue	YoY	EPS	Adj. EPS	Source
Q3 FY2026ended Sep 30, 2026	Oct 29, 2026Expected	–	–	–	–	–
Q2 FY2026ended Jun 30, 2026	Jul 30, 2026before the open	$71.70B	+6.7%	$6.29	$7.78	Release
Q1 FY2026ended Mar 31, 2026	Apr 30, 2026before the open	$68.50B	+4.6%	$6.26	$7.79	Release
Q4 FY2025ended Dec 31, 2025	Feb 5, 2026before the open	$72.47B	+10.4%	$4.64	$8.08	Release
Q3 FY2025ended Sep 30, 2025	Oct 30, 2025before the open	$69.70B	+9.4%	$6.98	$7.83	Release
Q2 FY2025ended Jun 30, 2025	Jul 31, 2025before the open	$67.20B	+11.1%	$5.71	$7.20	Release
Q1 FY2025ended Mar 31, 2025	May 2, 2025before the open	$65.50B	+14.3%	$4.85	$6.74	Release
Q4 FY2024ended Dec 31, 2024	Jan 30, 2025before the open	$65.65B	+28.4%	$5.13	$6.64	Release
Q3 FY2024ended Sep 30, 2024	Oct 31, 2024before the open	$63.70B	+30.0%	$2.63	$7.51	Release
Q2 FY2024ended Jun 30, 2024	Aug 1, 2024before the open	$60.50B	+24.5%	$5.45	$6.72	Release
Q1 FY2024ended Mar 31, 2024	May 2, 2024before the open	$57.30B	+23.2%	-$0.97	$6.47	Release
Q4 FY2023ended Dec 31, 2023	Feb 2, 2024before the open	$51.11B	+11.7%	$3.49	$6.79	Release
Q3 FY2023ended Sep 30, 2023	Nov 2, 2023before the open	$49.00B	+8.2%	$4.74	$6.77	Release
Q2 FY2023ended Jun 30, 2023	Aug 3, 2023before the open	$48.60B	+6.8%	–	–	Release
Q1 FY2023ended Mar 31, 2023	May 5, 2023before the open	$46.50B	+5.7%	$4.24	$5.41	Release
Q4 FY2022ended Dec 31, 2022	Feb 3, 2023before the open	$45.75B	+0.1%	$3.83	$4.96	Release
Q3 FY2022ended Sep 30, 2022	Nov 3, 2022before the open	$45.30B	+2.3%	$8.97	$6.04	Release
Q2 FY2022ended Jun 30, 2022	Aug 4, 2022before the open	$45.50B	–	$4.90	$6.22	Release
Q1 FY2022ended Mar 31, 2022	May 9, 2022after the close	$44.00B	–	$3.68	$6.01	Release
Q4 FY2021ended Dec 31, 2021	Feb 3, 2022before the open	$45.69B	–	$3.39	$4.77	Release
Q3 FY2021ended Sep 30, 2021	Nov 4, 2021before the open	$44.30B	–	$4.80	$5.73	Release
Q2 FY2021ended Jun 30, 2021	Aug 5, 2021before the open	–	–	–	–	Filing
Q1 FY2021ended Mar 31, 2021	May 7, 2021before the open	–	–	–	–	Filing
Q4 FY2020ended Dec 31, 2020	Feb 4, 2021before the open	–	–	–	–	Filing
Q3 FY2020ended Sep 30, 2020	Nov 5, 2020before the open	–	–	–	–	Filing
Q2 FY2020ended Jun 30, 2020	Jul 30, 2020before the open	–	–	–	–	Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Cigna's latest outlook for periods it has not reported yet, compared with what it said before

Metric	Period	Guidance	Before	Change	Given
Adjusted Revenuesnon-GAAP	FY2026	$280.00B	–	New	Feb 5, 2026
Evernorth Adjusted Income from Operations, Pre-Taxnon-GAAP	FY2026	$6.90B	$6.90B	Raised	Jul 30, 2026
Adjusted Income from Operations, per sharenon-GAAP	FY2026	$30.45	$30.35	Raised	Jul 30, 2026
Capital Expenditures	FY2026	$1.30B	–	New	Feb 5, 2026
Adjusted Effective Tax Ratenon-GAAP	FY2026	19%	–	Raised	Feb 5, 2026
Adjusted SG&A Expense Rationon-GAAP	FY2026	5%	–	New	Feb 5, 2026
Cash Flow from Operations	FY2026	$9.00B	–	New	Feb 5, 2026
Cigna Healthcare Medical Care Rationon-GAAP	FY2026	83.7% – 84.7%	–	Raised	Jul 30, 2026
Cigna Healthcare Medical Care Ratio	FY2026	83.7% – 84.7%	83.7% – 84.7%	Reaffirmed	Apr 30, 2026
Shareholder Dividends	FY2026	$1.60B	–	Lowered	Feb 5, 2026
Total Medical Customers	FY2026	18.1	–	Lowered	Feb 5, 2026
Weighted Average Shares Outstanding (millions)	FY2026	261 – 265	–	New	Feb 5, 2026

Guidance vs results

The last range Cigna gave before each report, against the figure it then reported. Full years add up the four quarters.

Period	Metric	Guidance	Actual	Result
FY2025	consolidated adjusted income from operations	$29.60	$29.85Σ4Q	Above range

Guidance history

Every forecast Cigna put in an earnings release, newest first

Given	Metric	Period	Guidance	Change
Jul 30, 2026	Adjusted Income from Operations, per share	FY2026	$30.45	Raised
Jul 30, 2026	Evernorth Adjusted Income from Operations, Pre-Tax	FY2026	$6.90B	Raised
Jul 30, 2026	Cigna Healthcare Adjusted Income from Operations, Pre-Tax	FY2026	$4.55B	Lowered
Jul 30, 2026	Cigna Healthcare Medical Care Ratio	FY2026	83.7% – 84.7%	Raised
Apr 30, 2026	Adjusted Income from Operations, per share	FY2026	$30.35	Raised
Apr 30, 2026	Evernorth Adjusted Income from Operations, Pre-Tax	FY2026	$6.90B	Raised
Apr 30, 2026	Cigna Healthcare Adjusted Income from Operations, Pre-Tax	FY2026	$4.53B	Lowered
Apr 30, 2026	Cigna Healthcare Medical Care Ratio	FY2026	83.7% – 84.7%	Reaffirmed
Feb 5, 2026	Capital Expenditures	FY2026	$1.30B	New
Feb 5, 2026	Adjusted Income from Operations, per share	FY2026	$30.25	New
Feb 5, 2026	Adjusted Income from Operations	FY2026	$7.95B	New
Feb 5, 2026	Evernorth Adjusted Income from Operations, Pre-Tax	FY2026	$6.90B	Lowered
Feb 5, 2026	Cigna Healthcare Adjusted Income from Operations, Pre-Tax	FY2026	$4.50B	Lowered
Feb 5, 2026	Weighted Average Shares Outstanding (millions)	FY2026	261 – 265	New
Feb 5, 2026	Total Medical Customers	FY2026	18.1	Lowered
Feb 5, 2026	Cigna Healthcare Medical Care Ratio	FY2026	83.7% – 84.7%	New
Feb 5, 2026	Adjusted SG&A Expense Ratio	FY2026	5%	New
Feb 5, 2026	Adjusted Effective Tax Rate	FY2026	19%	Raised
Feb 5, 2026	Cash Flow from Operations	FY2026	$9.00B	New
Feb 5, 2026	Shareholder Dividends	FY2026	$1.60B	Lowered
Feb 5, 2026	Adjusted Revenues	FY2026	$280.00B	New
Oct 30, 2025	consolidated adjusted income from operations	FY2025	$29.60	Reaffirmed
Oct 30, 2025	Evernorth Adjusted Income from Operations, Pre-Tax	FY2025	$7.20B	Raised
Oct 30, 2025	Cigna Healthcare Adjusted Income from Operations, Pre-Tax	FY2025	$4.13B	Lowered
Oct 30, 2025	Cigna Healthcare Medical Care Ratio	FY2025	83.2% – 84.2%	Reaffirmed
Jul 31, 2025	Adjusted Income from Operations, per share	FY2025	$29.60	New
Jul 31, 2025	Evernorth Adjusted Income from Operations, Pre-Tax	FY2025	$7.20B	New
Jul 31, 2025	Cigna Healthcare Adjusted Income from Operations, Pre-Tax	FY2025	$4.13B	Lowered
Jul 31, 2025	Cigna Healthcare Medical Care Ratio	FY2025	83.2% – 84.2%	New
May 2, 2025	Adjusted Income from Operations, per share	FY2025	$29.60	Raised
Jan 30, 2025	Capital Expenditures	FY2025	$1.40B	New
Jan 30, 2025	Adjusted Income from Operations, per share	FY2025	$29.50	New
Jan 30, 2025	Adjusted Income from Operations	FY2025	$7.90B	New
Jan 30, 2025	Evernorth Adjusted Income from Operations, Pre-Tax	FY2025	$7.20B	Lowered
Jan 30, 2025	Cigna Healthcare Adjusted Income from Operations, Pre-Tax	FY2025	$4.10B	Lowered
Jan 30, 2025	Weighted Average Shares Outstanding (millions)	FY2025	266 – 270	New
Jan 30, 2025	Total Medical Customers	FY2025	18.1	Lowered
Jan 30, 2025	Cigna Healthcare Medical Care Ratio	FY2025	83.2% – 84.2%	New
Jan 30, 2025	Adjusted SG&A Expense Ratio	FY2025	5.4%	New
Jan 30, 2025	Adjusted Effective Tax Rate	FY2025	19%	Raised
Jan 30, 2025	Cash Flow from Operations	FY2025	$10.00B	New
Jan 30, 2025	Shareholder Dividends	FY2025	$1.60B	Lowered
Jan 30, 2025	Adjusted Revenues	FY2025	$252.00B	New
Oct 31, 2024	Adjusted Income from Operations, per share	FY2024	$28.40	Reaffirmed
Oct 31, 2024	Evernorth Adjusted Income from Operations, Pre-Tax	FY2024	$7.00B	Lowered
Oct 31, 2024	Cigna Healthcare Adjusted Income from Operations, Pre-Tax	FY2024	$4.78B	Lowered
Oct 31, 2024	Cigna Healthcare Medical Care Ratio	FY2024	81.7% – 82.5%	Reaffirmed
Aug 1, 2024	adjusted income from operations per share	FY2024	$28.40	Reaffirmed
Aug 1, 2024	consolidated adjusted income from operations	FY2024	$8.07B	Raised
Aug 1, 2024	Weighted Average Shares Outstanding (millions)	FY2024	282 – 286	Raised
Aug 1, 2024	Total Medical Customers	FY2024	19.3	Lowered
Aug 1, 2024	Medical Care Ratio	FY2024	81.7% – 82.5%	Reaffirmed
Aug 1, 2024	Adjusted SG&A Expense Ratio	FY2024	6.1%	Lowered
Aug 1, 2024	Adjusted Effective Tax Rate	FY2024	20.5% – 21%	Raised
Aug 1, 2024	Cash Flow from Operations	FY2024	$11.00B	Reaffirmed
Aug 1, 2024	adjusted revenues	FY2024	$235.00B	Reaffirmed
May 2, 2024	adjusted income from operations per share	FY2024	$28.40	Raised
May 2, 2024	consolidated adjusted income from operations	FY2024	$8.07B	Raised
May 2, 2024	Adjusted Income from Operations, Pre-Tax	FY2024	$7.00B	Lowered
May 2, 2024	Adjusted Income from Operations, Pre-Tax	FY2024	$4.78B	Lowered
May 2, 2024	Weighted Average Shares Outstanding (millions)	FY2024	282 – 286	Raised
May 2, 2024	Total Medical Customers	FY2024	19.3	Lowered
May 2, 2024	Medical Care Ratio	FY2024	81.7% – 82.5%	Lowered
May 2, 2024	Adjusted SG&A Expense Ratio	FY2024	6.1%	Lowered
May 2, 2024	Adjusted Effective Tax Rate	FY2024	20.5% – 21%	Raised
May 2, 2024	Cash Flow from Operations	FY2024	$11.00B	Raised
May 2, 2024	adjusted revenues	FY2024	$235.00B	Reaffirmed
Feb 2, 2024	Capital Expenditures	FY2024	$1.50B	New
Feb 2, 2024	adjusted income from operations, per share	FY2024	$28.25	New
Feb 2, 2024	consolidated adjusted income from operations	FY2024	$8.03B	New
Feb 2, 2024	Weighted Average Shares Outstanding (millions)	FY2024	282 – 286	New
Feb 2, 2024	Total Medical Customers	FY2024	19.3	Lowered
Feb 2, 2024	Medical Care Ratio	FY2024	81.7% – 82.7%	New
Feb 2, 2024	Adjusted SG&A Expense Ratio	FY2024	6.1%	New
Feb 2, 2024	Adjusted Effective Tax Rate	FY2024	20.5% – 21%	Raised
Feb 2, 2024	Cash Flow from Operations	FY2024	$11.00B	New
Feb 2, 2024	Shareholder Dividends	FY2024	$1.55B	Lowered
Feb 2, 2024	adjusted revenues	FY2024	$235.00B	New
Nov 2, 2023	consolidated adjusted income from operations, per share	FY2023	$24.75	Raised
Nov 2, 2023	consolidated adjusted income from operations	FY2023	$7.36B	Reaffirmed
Nov 2, 2023	Weighted Average Shares Outstanding (millions)	FY2023	296 – 298	Lowered
Nov 2, 2023	Total Medical Customer Growth	FY2023	1,600,000	Raised
Nov 2, 2023	Medical Care Ratio	FY2023	81.5% – 82%	Lowered
Nov 2, 2023	Adjusted SG&A Expense Ratio	FY2023	7.4%	Lowered
Nov 2, 2023	Adjusted Effective Tax Rate	FY2023	20.5% – 21%	Raised
Nov 2, 2023	Cash Flow from Operations	FY2023	$10.50B	Raised
Nov 2, 2023	adjusted revenues	FY2023	$192.00B	Raised
May 5, 2023	adjusted income from operations	FY2023	$24.70	Raised
May 5, 2023	consolidated adjusted income from operations	FY2023	$7.36B	Raised
May 5, 2023	adjusted revenues	FY2023	$188.00B	Raised
Feb 3, 2023	Capital Expenditures	FY2023	$1.40B	New
Feb 3, 2023	Adjusted Income from Operations, per share	FY2023	$24.60	New
Feb 3, 2023	consolidated adjusted income from operations	FY2023	$7.33B	New
Feb 3, 2023	Weighted Average Shares Outstanding (millions)	FY2023	296 – 300	New
Feb 3, 2023	Total Medical Customer Growth (lives)	FY2023	1,200,000	Raised
Feb 3, 2023	Medical Care Ratio	FY2023	81.5% – 82.5%	New
Feb 3, 2023	Adjusted SG&A Expense Ratio	FY2023	7.3%	New
Feb 3, 2023	Adjusted Effective Tax Rate	FY2023	21% – 21.5%	Raised
Feb 3, 2023	Cash Flow from Operations	FY2023	$9.00B	New
Feb 3, 2023	Shareholder Dividends	FY2023	$1.45B	Lowered
Feb 3, 2023	adjusted revenues	FY2023	$187.00B	New
Nov 3, 2022	Adjusted income from operations, per share	FY2022	$23.10	Raised
Nov 3, 2022	consolidated adjusted income from operations	FY2022	$7.23B	Raised
Nov 3, 2022	Adjusted Revenues	FY2022	$179.00B	Raised
Aug 4, 2022	adjusted income from operations per share	FY2022	$22.90	Raised
Aug 4, 2022	consolidated adjusted income from operations	FY2022	$7.17B	Raised
Aug 4, 2022	Weighted Average Shares Outstanding (millions)	FY2022	312 – 314	Lowered
Aug 4, 2022	Total Medical Customer Growth (lives)	FY2022	800,000	Raised
Aug 4, 2022	Adjusted SG&A Expense Ratio	FY2022	7.1% – 7.3%	Lowered
Aug 4, 2022	Adjusted Tax Rate	FY2022	22% – 22.5%	Raised
Aug 4, 2022	Medical Care Ratio	FY2022	81.5% – 82.5%	Raised
Aug 4, 2022	Cash Flow from Operations	FY2022	$8.50B	Raised
Aug 4, 2022	Adjusted Income from Operations, Pre-Tax (Evernorth)	FY2022	$6.13B	New
Aug 4, 2022	Adjusted Income from Operations, Pre-Tax (Cigna Healthcare)	FY2022	$4.03B	Lowered
Aug 4, 2022	adjusted revenues	FY2022	$178.00B	Raised
May 9, 2022	adjusted income from operations per share	FY2022	$22.60	Raised
May 9, 2022	consolidated adjusted income from operations	FY2022	$7.05B	Raised
May 9, 2022	adjusted revenues	FY2022	$177.00B	Reaffirmed
Feb 3, 2022	Capital Expenditures	FY2022	$1.25B	New
Feb 3, 2022	consolidated adjusted income from operations, per share	FY2022	$22.40	New
Feb 3, 2022	consolidated adjusted income from operations	FY2022	$6.95B	New
Feb 3, 2022	Adjusted Margin, After-Tax	FY2022	3.9%	New
Feb 3, 2022	Weighted Average Shares Outstanding (millions)	FY2022	308 – 312	New
Feb 3, 2022	Total Medical Customer Growth (lives)	FY2022	575,000	Raised
Feb 3, 2022	SG&A Expense Ratio	FY2022	6.9% – 7.3%	New
Feb 3, 2022	Adjusted Tax Rate	FY2022	22% – 22.5%	Raised
Feb 3, 2022	Medical Care Ratio	FY2022	82% – 83.5%	Raised
Feb 3, 2022	Cash Flow from Operations	FY2022	$8.25B	New
Feb 3, 2022	Shareholder Dividends	FY2022	$1.40B	Lowered
Feb 3, 2022	adjusted revenues	FY2022	$177.00B	New
Nov 4, 2021	adjusted income from operations per share	FY2021	$20.35	New
Nov 4, 2021	consolidated adjusted income from operations	FY2021	$6.96B	New
Nov 4, 2021	adjusted revenues	FY2021	$172.00B	New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.